Zimmer Biomet Holdings Inc
General ticker "ZBH" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $22.0B
Zimmer Biomet Holdings Inc does not follow the US Stock Market performance with the rate: -25.1%.
Estimated limits based on current volatility of 1.2%: low 105.13$, high 107.70$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-09-30, amount 0.24$ (Y0.90%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [108.52$, 155.16$]
- 2024-12-30 to 2025-12-30 estimated range: [113.39$, 162.59$]
Financial Metrics affecting the ZBH estimates:
- Positive: Non-GAAP EPS, $ of 7.56 > 2.29
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: 9.05 < Operating profit margin, % of 17.28
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 4.55
- Negative: Investing cash flow per share, $ of -3.73 <= -3.48
Short-term ZBH quotes
Long-term ZBH plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7,836.20MM | $6,939.90MM | $7,394.20MM |
| Operating Expenses | $7,056.10MM | $6,243.60MM | $6,116.50MM |
| Operating Income | $780.10MM | $696.30MM | $1,277.70MM |
| Non-Operating Income | $-361.70MM | $-292.80MM | $-210.40MM |
| Interest Expense | $208.40MM | $164.80MM | $201.20MM |
| R&D Expense | $435.80MM | $406.00MM | $458.70MM |
| Income(Loss) | $418.40MM | $403.50MM | $1,067.30MM |
| Taxes | $16.30MM | $112.30MM | $43.30MM |
| Other Income(Loss) | $0.00MM | $-58.80MM | $0.00MM |
| Profit(Loss) | $402.10MM | $232.40MM | $1,024.00MM |
| Stockholders Equity | $-231.60MM | $12,020.30MM | $12,480.50MM |
| Inventory | $2,148.00MM | $2,147.20MM | $2,385.20MM |
| Assets | $23,456.40MM | $21,066.00MM | $21,496.90MM |
| Operating Cash Flow | $1,499.20MM | $1,284.70MM | $1,581.60MM |
| Capital expenditure | $152.00MM | $187.90MM | $602.80MM |
| Investing Cash Flow | $-503.60MM | $-529.20MM | $-778.90MM |
| Financing Cash Flow | $-1,306.00MM | $-843.80MM | $-763.50MM |
| Earnings Per Share* | $1.93 | $1.39 | $4.91 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.